Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech

Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
Near Frontier
Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
/
Episode 4 February 22, 2022 00:56:28

Hosted By

Ian Rountree Amee Kapadia Andrew Kirima

Show Notes

Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message. 

Shownotes:

Other Episodes

August 24, 2022

The Fourth Pillar of Cancer w/ Anand Parikh of Faeth Therapeutics

Today we're joined by Anand Parikh, founder and CEO of Faeth Therapeutics. Faeth combines precision nutrition, therapeutics, and digital health to deliver a cancer-fighting program designed to deprive tumors of the nutrients they need to grow while providing optimal nutritional support to healthy tissues.  In this episode, we get into what led Anand to start Faeth, dig into the operational complexity behind the business's software, therapeutics, and nutrition aspects, discuss fundraising for an unconventional business model, and more.  Get in touch— Anand's socials Enroll in Faeth's clinical trials here Check out Faeth's open roles here   ...

Play

00:59:58

January 25, 2022

RNA Delivery with Anna Perdrix and George Foot of Sixfold Bioscience

Today we're joined by Anna Perdrix Rossell and George Foot of Sixfold Bioscience, co-founders of Sixfold Bioscience, a UK based biotech company using computation and advanced chemistry to engineer highly programmable constructs that make the delivery of RNA therapeutics predictable and precise. Sixfold's technology expands the purview of RNA therapeutics from vaccines to all diseases, starting with cancer. In our conversation, we discuss the challenge of RNA delivery, what it's like starting a biotech company totally from scratch (no academic spinout or venture incubation), how to hire a diverse team, and promising areas of biotechnology.    Shownotes: Get in touch with the Sixfold team: Sixfold Bioscience; George Foot; Anna Perdrix Interested in joining the team? Check out open roles here In this episode, we cover:  Sixfold Bioscience and challenges with RNA delivery  How George and Anna started Sixfold Switching between an academia and entrepreneurship mindset Building a biotech totally from scratch Twitter debate—founder led bio vs venture incubation  Building a diverse (majority women!) team and tips for recruitment Sixfold's big vision Broader trends to be excited about in biotech and deep tech ...

Play

00:43:57

January 11, 2022

Orbital Ubers with Vanessa Clark and William Kowalski of Atomos Space

Today we're joined by Vanessa Clark and William Kowalski, cofounders of Atomos Space, an aerospace company transforming how we operate in space with orbital transfer vehicles. In our conversation, we discuss the importance of orbital transfer vehicles or "space taxis", regulations when operating in space, and the early days of Atomos. We hope you enjoy our conversation with Vanessa and William.  Shownotes: Track items in orbit: http://stuffin.space/ Get in touch with the Atomos crew: Atomos Space; Vanessa Clark; William Kowalski  In this episode, we cover:  Orbital transfer vehicles (OTVs) Kessler Syndrome  Regulatory landscape in space Working with the government as a private space company Nuclear propulsion How Atomos came to be Early days of fundraising How to hire a rockstar team ...

Play

00:49:06